M
Mark S. Litwin
Researcher at University of California, Los Angeles
Publications - 480
Citations - 31421
Mark S. Litwin is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Prostate cancer & Prostatectomy. The author has an hindex of 86, co-authored 464 publications receiving 29048 citations. Previous affiliations of Mark S. Litwin include University of California, San Francisco & Oklahoma State University Center for Health Sciences.
Papers
More filters
Journal ArticleDOI
Quality of life and satisfaction with outcome among prostate-cancer survivors.
Martin G. Sanda,Rodney L. Dunn,Jeff M. Michalski,Howard M. Sandler,Laurel L. Northouse,Larry Hembroff,Xihong Lin,Thomas K. Greenfield,Mark S. Litwin,Mark S. Litwin,Christopher S. Saigal,Arul Mahadevan,Eric A. Klein,Adam S. Kibel,Louis L. Pisters,Deborah A. Kuban,Irving D. Kaplan,Darien Wood,Jay P. Ciezki,Nikhil L. Shah,John T. Wei +20 more
TL;DR: Each prostate-cancer treatment was associated with a distinct pattern of change in quality-of-life domains related to urinary, sexual, bowel, and hormonal function, and these changes influenced satisfaction with treatment outcomes among patients and their spouses or partners.
Book
How to Measure Survey Reliability and Validity
TL;DR: How to Measure Survey Reliability and Validity Learning Objectives Overview of Psychometrics Reliability Validity Scaling and Scoring Creating and Using a Codebook Pilot Testing Multicultural Issues
Journal ArticleDOI
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer.
TL;DR: EPIC is a robust prostate cancer HRQOL instrument that complements prior instruments by measuring a broad spectrum of urinary, bowel, sexual, and hormonal symptoms, thereby providing a unique tool for comprehensive assessment ofHRQOL issues important in contemporary prostate cancer management.
Journal ArticleDOI
Quality-of-life Outcomes in Men Treated for Localized Prostate Cancer
Mark S. Litwin,Ron D. Hays,Arlene Fink,Patricia A. Ganz,Barbara Leake,Gary E. Leach,Robert H. Brook +6 more
TL;DR: It is concluded that in addition to general HRQOL, disease-targeted measures must be used to assess outcomes of care in men treated for localized prostate cancer.
Journal ArticleDOI
The Diagnosis and Treatment of Prostate Cancer: A Review.
Mark S. Litwin,Hung-Jui Tan +1 more
TL;DR: Advances in the diagnosis and treatment of prostate cancer have improved the ability to stratify patients by risk and allowed clinicians to recommend therapy based on cancer prognosis and patient preference.